检索

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

卷 30, 编号 3 (2023)

Glycemic variability diary as a tool for assessing the effectiveness of diabetes therapy. Clear and accessible. Case series

Smirnova E.

(Rus)

卷 30, 编号 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Vildagliptin – 15 years in active service with diabetologists

Pavlova M.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

The use of dulaglutide in real clinical practice in patients with type 2 diabetes mellitus in Moscow

Antsiferov M., Antsiferova D., Koteshkova O., Demidov N.

(Rus)

Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation

Ignatenko A., Bagriy A., Prikolota A., Prikolota O., Mikhailichenko E., Golodnikov I., Bagriy O.

(Rus)

Modern possibilities for assessing glycemia in diabetic patients

Chernikova N., Degtyareva E.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

How to improve the quality of type 2 diabetes mellitus management in routine clinical practice. experience of using a glycemic variability diary

Astamirova K., Gatina A., Gorbunova Y., Demidov N., Ivanenko T., Kolesnikova M., Lapteva O., Morozova I., Parshina V., Presnyakova O., Smirnova E., Smirnova N., Startseva M., Khamrazhanov Z., Kholmskaya N.

(Rus)

Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus

Demicheva T.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

编号 20 (2014)

Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta

Gromova O., Torshin I., Limanova O., Grishina T., Gromov A.

(Rus)

Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus

Bagriy A., Shchukina E., Efremenko V., Mikhailichenko E., Suprun E.

(Rus)

News of medicine

Kudinova S.

(Rus)

Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice

Antsiferov M., Zilov A., Koteshkova O., Demidov N.

(Rus)

编号 10 (2012)

Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii

Ametov A., Valitov B., Chernikova N., Antsiferov M.

(Rus)

编号 5 (2017)

PATHOPHYSIOLOGICAL APPROACH AS A BASIS FOR THE SELECTION OF STRATEGY FOR THE SUCCESS TREATMENT OF TYPE 2 DIABETES MELLITUS

Ametov A.

(Rus)

编号 11 (2012)

Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya

Mayorov A.

(Rus)

卷 29, 编号 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

编号 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

编号 3 (2012)

DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE

Peterkova V., Peterkova V.

编号 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

编号 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

卷 27, 编号 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

编号 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

编号 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

编号 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

卷 29, 编号 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

卷 27, 编号 12 (2020)

Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»

Antsiferov M., Galstyan G.

(Rus)

卷 27, 编号 4 (2020)

Mkrtumyan A., Markova T.

(Rus)

The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)

Antsiferov M., Kvasnikov B.

(Rus)

编号 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

编号 2 (2018)

Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus

Fedorchenko Y., Martynyuk M.

(Rus)

编号 6 (2017)

THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS

Shevkunova N.

(Rus)

编号 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

编号 17 (2015)

Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa

Galstyan G.

(Rus)

编号 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

编号 16 (2013)

Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa

Ametov A.

(Rus)

编号 10 (2013)

Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa

Demidova I., Boeva V.

(Rus)

编号 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

编号 3 (2012)

SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Nikonova T., Nikonova T.

编号 16 (2011)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antciferov M.

编号 3 (2011)

COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Trukhina L., Petunina N., Truhina L.

编号 16 (2010)

WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Petunina N.

编号 3 (2010)

Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)

Antsiferov M., Antsiferov M.

卷 29, 编号 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

卷 27, 编号 12 (2020)

Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes

Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.

(Rus)

Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice

Markova T.

(Rus)

编号 11 (2018)

Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use

Biryukova E.

(Rus)

编号 16 (2016)

Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus

Antsiferov M.

(Rus)

编号 5 (2016)

APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS

Antsiferov M.

(Rus)

编号 13 (2015)

Sakharosnizhayushchaya terapiya i serdechno- sosudistaya bezopasnost'

Pashentseva A., Verbovoy A.

(Rus)

编号 5 (2015)

Klinicheskaya inertsiya v terapii sakharnogo diabeta 2 tipa

Antsiferov M.

(Rus)

编号 16 (2013)

Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa

Statsenko M., Derevyanchenko M.

(Rus)

编号 3 (2012)

HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?

Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.

编号 16 (2011)

DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 3 (2011)

INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES

Antsiferov M., Koteshkova O., Kleymenova S., Antsiferov M., Koteshkova O., Kleimenko S.

编号 16 (2010)

INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH

Biryukova Y., Biryukova E.

编号 5 (2010)

Thiazide diuretics and arterial hypertension: the history is going on

E Chazova I., Fomin V., Chazova I., Fomin V.

编号 15 (2009)

Insulin resistance and heart diseases: is there a relationship?

Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.

School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus

Lisker A., Volkova A., Chernaya M., Mozgunova V., Durdyeva M.

(Rus)

Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy

Zelenina T., Salukhov V., Zemlyanoy A., Chebykina O.

(Rus)

卷 27, 编号 12 (2020)

Improvement of the efficacy of conservative treatment of rhinosinusitis and otitis media in patients with type 2 diabetes mellitus: an open-label prospective randomized clinical trial

Shkurova N., Baranova N., Fedin A.

(Rus)

Do we know everything about the possibilities of metformin in the treatment of type 2 diabetes mellitus? Which of its combinations is the most studied, effective and available for the patient in the real practice of the endocrinologist?

Biryukova E., Solovyova I.

(Rus)

编号 16 (2017)

Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus

Tsvetkova I., Kaukova A., Belyakova N., Vasyutkova O., Konovalova O., Lareva A.

(Rus)

编号 16 (2016)

Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients

Kovrigina E., Tyulganova V.

(Rus)

编号 2 (2016)

ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS

Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.

(Rus)

编号 5 (2014)

VLIYaNIE KOMBINATsII METFORMINA I VILDAGLIPTINA NA POKAZATELI UGLEVODNOGO I ZhIROVOGO OBMENOV U BOL'NYKh SAKhARNYM DIABETOM 2 TIPA

Abaeva M., Nazhmutdinova P., Ametov A.

(Rus)

编号 16 (2013)

Dolgosrochnaya bezopasnost' i effektivnost' insulina aspart u patsientov s sakharnym diabetom 1 tipa

Antsiferov M.

(Rus)

编号 5 (2013)

PREIMUShchESTVA METFORMINA PROLONGIROVANNOGO DEYSTVIYa

Petunina N., Trukhina L., Sinitsyna E., Antsiferov M.

(Rus)

编号 20 (2012)

Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov

Ruyatkina L., Sorokin M.

(Rus)

编号 9 (2012)

METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA

Verbovoy A., Vorozhtsova E., Orlova T.

(Rus)

编号 3 (2012)

SULFONYLUREAS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS TODAY. IS THERE A PROSPECT?

Kononenko I., Smirnova O., Smirnova O., Kononenko I.

编号 16 (2011)

SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.

编号 3 (2011)

HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS

Biryukova E., pl?midmagidsid Y.

编号 16 (2010)

CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS

Antsiferov M., Koteshkova O., Kleimenova S., Antsiferov M., Koteshkova O., Kleymenova S.

编号 3 (2010)

Common bean (Phaseolus vulgaris L.)/

Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.

卷 29, 编号 4 (2022)

Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin

Novikova M., Koteshkova O., Antsiferov M.

(Rus)

P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy

Chernikova N.

(Rus)

The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus

Shevkunova N., Vorobyov M., Gushchin V.

(Rus)

卷 27, 编号 4 (2020)

Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors

Chernikova N., Knyshenko O.

(Rus)